**YOU MUST REGISTER OR LOG IN TO ACCESS THE REGISTRATION FORM**
Mid-West Chapter Meeting: August 21-22
Virtual meeting will be on CT
Physician or equivalent: $110: Member / $135: Non-Member
Non-physician: $85: Member / $110: Non-Member
CHAPTER CANCELLATION/REFUND POLICY: $50 administrative fee will be held on all cancellations three (3) months prior to start of meeting date. 50% of fees will be held on all cancellations one (1) month to two weeks prior to start of meeting date. NO REFUNDS two weeks prior to or after the meeting date.
|Event Start Date||08-21-2021|
|Event End Date||08-22-2021|
|Categories||UHMS Directly Provided Meeting|
Andrew Melnyczenko's combined military and civilian experience in Hyperbaric Medicine spans 23 years. He is the Technical and Safety Director of the Hyperbaric and Altitude Medicine Program at the Mayo Clinic. He is also a UHMS member and serves as the chair of the UHMS safety committee. Andrew’s professional interests lie in education, emergency preparedness, and advancing the practical use of Hyperbaric Oxygen Therapy.
Dr. Feldmeier received his D.O. degree from The Philadelphia College of Osteopathic Medicine in 1979 with USAF sponsorship and completed residency training in Radiation Oncology at the University of Texas Health Science Center at San Antonio, Texas in 1985. He received a fellowship certificate from the USAF Hyperbaric Medicine Fellowship Training Program at Brooks Air Force Base in San Antonio, Texas and was a staff physician there from 1980 to 1982. Dr. Feldmeier was simultaneously the Chief of Radiation Oncology and Chairman of the Hyperbaric Medicine Department at Wright-Patterson Air Force Base Medical Center in Dayton, Ohio before separating from the USAF in 1985. Dr. Feldmeier has served as the Chief of Radiation Oncology at the University of Texas Health Science Center in San Antonio, Grace Hospital in Detroit, MI and the Chairman of Radiation Oncology at the University of Toledo Medical Center from which he retired in 2013 with the award of Professor Emeritus. Dr. Feldmeier has authored numerous publications in both radiation oncology and hyperbaric medicine. He has been the editor of the Undersea & Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report. He served as review editor of Undersea and Hyperbaric Medicine. He is a Fellow of Undersea and Hyperbaric Medicine and Past- President of the UHMS. He currently co-chairs the UHMS Research Committee. He is a Fellow of the American College of Radiation Oncology. He is a medical consultant to International ATMO. He is the only physician in the U.S. board certified in both Radiation Oncology and Undersea and Hyperbaric Medicine.
Kyle DuBose graduated from the West Virginia School of Osteopathic Medicine in 2013. He completed his primary training in Family Medicine and Osteopathic Manipulative Treatment at Broward Health Medical Center in Fort Lauderdale, FL. Subsequently, he completed his fellowship training in Hyperbaric and Undersea Medicine at Kent Hospital in Warwick, RI. He has worked at Advocate Aurora Health since August 2017 as the lead physician at Aurora Medical Center Kenosha’s Comprehensive Hyperbaric Medicine and Wound Care Clinic. He chairs the Utilization Review Committee for the Hyperbaric Medicine Department at Advocate Aurora Health. He was involved in helping create the Hyperbaric and Undersea Medicine Fellowship at Advocate Aurora Health and is currently one of the faculty attendings for the program. In 2017, he helped create and leads the Limb Salvage Team at Aurora Medical Center Kenosha. Dr. DuBose also served on the Medical Executive Committee at Aurora Medical Center Kenosha.
Dr. Gesell is the System Director for Hyperbaric Medicine and Wound Care with Advocate Aurora Medical Group and Section Chair for Undersea and Hyperbaric Medicine. She is board certified in Emergency Medicine and Undersea & Hyperbaric Medicine. Dr. Gesell is a Fellow of the American College of Emergency Physicians, as well as, the Undersea and Hyperbaric Medical Society. Dr. Gesell is a Past President of the Undersea and Hyperbaric Medical Society, Past Chair of the UHMS Board of Directors, and former Chair of the UHMS Hyperbaric Oxygen Therapy Committee. Dr. Gesell represents the medical specialty as the UHMS Delegate in the AMA House of Delegates and is the elected American Board of Preventive Medicine Undersea and Hyperbaric Medicine Sub-Board Chair.
Marc Robins, DO, MPH, FUHM is the Senior Medical Director for the Wound & Hyperbaric Shared Services for the Intermountain Healthcare System in Utah. He is the current President of the UHMS and has served as Co-Chair for the Quality Utilization, Authorization and Reimbursement Committee and on the Education Committee for the UHMS. He is an Associate Fellow of the Aerospace Medical Association (AsMA) and has served on the Science and Research committee AsMA since 2001-20. He is boarded in Hyperbaric Medicine, Aerospace and Occupational Medicine and Family Practice and retired as a Colonel from the USAF after a 20-year career in Aerospace Medicine.
Dr. Omar Aljitawi is an Associate Professor in the Division of Hematology/Oncology at the University of Rochsester Medical Center. His research is focused on the development of translational research approaches and strategies to improve hematopoietic stem cell (HSC) homing and engraftment during HSC transplantation for the treatment of hematological malignancies. He has specific expertise in umbilical cord blood (UCB) stem cell homing and engraftment and the application of hyperbaric oxygen therapy as a modality to improve HSC engraftment. In fact, he discovered the importance of erythropoietin (EPO) signaling through its receptor on UCB stem cell homing and engraftment. Also, he was the PI on the first two published human studies involving the use of hyperbaric oxygen as a modality to reduce EPO and EPO-EPOR signaling in HSC transplantation. During the last decade, he have moved this project and concept from the lab and translated it to a bedside intervention. They are now conducting phase II randomized clinical trial in autologous stem cell transplantation treating multiple myeloma, a phase II randomized clinical trial in UCB transplantation, and a pilot study in allogeneic stem cell transplantation.
|Sat. Aug 21: 8:00-8:30||
UHMS President's address
Marc Robins, DO
|Sat., Aug 21: 8:30 - 9:30 am||
Limb Salvage: The next step for wound care
Kyle DuBose, DO
|Sat., Aug 21: 9:30-10:00||
Innovative TeleWound to optimize patient care and safety
Laurie Gesell, MD
|Sat., Aug 21:10:30-11:00||
COVID-19: The refined approach to safe & effective chamber cleaning
Scott Schlenner, CHT
|Sat., Aug 21:11:00-12:00||
The plastic surgery perspective: Safe and effective limb salvage with reconstructive surgery and hyperbaric oxygen
John Felder, MD
|Sat., Aug 21:12:30-1:15||
Vascular surgery and limb preservation
Vipul Khetarpaul, MD
|Sat., Aug 21: 1:15-2:00||
Critical Care Considerations: Safe, effective use of HBO2 for Critically Ill and Inpatient Based Indications
John Kirby, MD
|Sat., Aug 21: 2:00-2:30||
Scenario-based exercise planning for operational emergencies in the hyperbaric environment.
Andrew Melnyczenko/Nick Marosek:
Part I (Andrew Melnyczenko, CHT) – Developing a tabletop exercise and emergency drill for the topic of Code Blue in the Multiplace Hyperbaric Chamber.
Part II (Nick Marosek, R.N., ACHRN) – Assessing performance of scenario-based emergency preparedness exercises, recognizing continuous improvement opportunities, and enhancing response plans.
|Sat., Aug 21: 2:30-3:00||
|Sun., Aug 22: 8:00-9:00||
It takes a village to raise a necrotizing fasciitis patient
Itamar Gnatt, MD
|Sun., Aug 22: 9:00-10:00||
Hyperbaric oxygen as adjunct in BMT
Dennis Allin, MD
|Sun., Aug 22: 10:30-11:30||
Hyperbaric therapy: Ethical considerations
Piroska Kopar, MD
|Sun., Aug 22: 11:30-12:00||
Checklist: Not just a documentation exercise
Rob Sheffield, CHT
|Sun., Aug 22: 12:00-12:30||
Selecting materials for hyperbaric use
Rob Sheffield, CHT
|Sun., Aug 22: 1:00-2:00||
Radiation Oncology Primer: Introduction to the biology of treatment and pathophysiology of complications
John Feldmeier, DO
Dr. Feldmeier will also review some of the newer radiation techniques that are designed to decrease complications. Because of significant advances in imaging and radiation treatment equipment, patients are receiving higher but more targeted doses. Several papers suggest that the result has been a lower complication rate while other experiences report a similar or even higher rate of radiation injury. The protective effect of targeted treatments is somewhat muted by the higher doses and the use of concurrent chemotherapy.in many cases. The net result of the increased but targeted doses has been a better impact on the tumor but a complication rate that is comparable to results from the past.
Finally, Dr. Feldmeier will briefly discuss the potential for hyperbaric oxygen in treating severe acute injuries.
|Sun., Aug 22: 2:00-3:00||
Q/A Panel Session: COVID related procedure considerations and HBO2 use for COVID